Forti G - Search Results

1

EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).

Bonaccorsi L, Carloni V, Muratori M, Formigli L, Zecchi S, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. Int J Cancer. 2004 Oct 20;112(1):78-86. doi: 10.1002/ijc.20362. Int J Cancer. 2004. PMID: 15305378

2

Androgen receptor and prostate cancer invasion.

Bonaccorsi L, Muratori M, Carloni V, Zecchi S, Formigli L, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. Int J Androl. 2003 Feb;26(1):21-5. doi: 10.1046/j.1365-2605.2003.00375.x. Int J Androl. 2003. PMID: 12534934 Review.

3

Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.

Bonaccorsi L, Marchiani S, Muratori M, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. J Cancer Res Clin Oncol. 2004 Oct;130(10):604-14. doi: 10.1007/s00432-004-0581-8. Epub 2004 Jul 16. J Cancer Res Clin Oncol. 2004. PMID: 15258753

4

Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.

Bonaccorsi L, Marchiani S, Ferruzzi P, Muratori M, Crescioli C, Forti G, Maggi M, Baldi E. Bonaccorsi L, et al. Among authors: forti g. Steroids. 2006 Apr;71(4):304-9. doi: 10.1016/j.steroids.2005.09.010. Epub 2005 Nov 9. Steroids. 2006. PMID: 16289173 Review.

5

The androgen receptor and prostate cancer invasion.

Bonaccorsi L, Muratori M, Marchiani S, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. Mol Cell Endocrinol. 2006 Feb 26;246(1-2):157-62. doi: 10.1016/j.mce.2005.11.006. Epub 2005 Dec 20. Mol Cell Endocrinol. 2006. PMID: 16376012

6

The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells.

Marchiani S, Bonaccorsi L, Ferruzzi P, Crescioli C, Muratori M, Adorini L, Forti G, Maggi M, Baldi E. Marchiani S, et al. Among authors: forti g. J Cancer Res Clin Oncol. 2006 Jun;132(6):408-16. doi: 10.1007/s00432-006-0086-8. Epub 2006 Feb 17. J Cancer Res Clin Oncol. 2006. PMID: 16485114

7

Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.

Bonaccorsi L, Nosi D, Muratori M, Formigli L, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. J Mol Endocrinol. 2007 Feb;38(1-2):51-66. doi: 10.1677/jme.1.02155. J Mol Endocrinol. 2007. PMID: 17242169

8

Prostate cancer: a model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model.

Bonaccorsi L, Nosi D, Quercioli F, Formigli L, Zecchi S, Maggi M, Forti G, Baldi E. Bonaccorsi L, et al. Among authors: forti g. Steroids. 2008 Oct;73(9-10):1030-7. doi: 10.1016/j.steroids.2008.01.028. Epub 2008 Feb 15. Steroids. 2008. PMID: 18358509 Review.

9

Signal transduction pathways in human spermatozoa.

Baldi E, Luconi M, Bonaccorsi L, Forti G. Baldi E, et al. Among authors: forti g. J Reprod Immunol. 2002 Jan;53(1-2):121-31. doi: 10.1016/s0165-0378(01)00089-4. J Reprod Immunol. 2002. PMID: 11730910 Review.

10

Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells.

Crescioli C, Maggi M, Luconi M, Vannelli GB, Salerno R, Sinisi AA, Bonaccorsi L, Ferruzzi P, Barni T, Forti G, Serio M. Crescioli C, et al. Among authors: forti g. Prostate. 2002 Jan 1;50(1):15-26. doi: 10.1002/pros.10028. Prostate. 2002. PMID: 11757032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters